Acasti Pharma Balance Sheet - Quarterly (NASDAQ:ACST)

Add to My Stocks
$0.72 $0.03 (4%) ACST stock closing price Jun 22, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Acasti Pharma stock analysis. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Acasti Pharma stock analysis. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. The Acasti Pharma balance sheet for 2017 Q1 shows total assets of $20.1M. The company has a asset turnover ratio of -. Also see: Acasti Pharma revenue and Acasti Pharma operating cash flow for the same quarter.

View and download Acasti Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Cash8.06M1.36M2.22M1.06M2.32M3.59M
Marketable Securities-3.03M4.03M4.76M5.71M7.08M
Receivables------
Inventory------
Raw Materials------
Work In Progress------
Finished Goods------
Notes Receivable------
Other Current Assets------
Total Current Assets
8.32M4.65M6.57M6.64M8.68M11.2M
Property Plant & Equipment2.45M-----
Accumulated Depreciation------
Net Property Plant & Equipment
2.18M1.69M----
Investment & Advances---1.53M1.53M-
Other Non-Current Assets------
Deferred Charges------
Intangibles9.59M9.92M10.59M11.01M11.43M11.99M
Deposits & Other Assets------
Total Assets
20.1M16.27M18.15M19.8M21.87M23.43M
Notes Payable------
Accounts Payable1.82M1.31M1.04M1.14M-1.2M
Current Portion Long-Term Debt------
Current Portion Capital Leases------
Accrued Expenses------
Income Taxes Payable------
Other Current Liabilities------
Total Current Liabilities
1.83M1.32M1.14M1.14M-1.23M
Mortgages------
Deferred Taxes/Income------
Convertible Debt------
Long-Term Debt1.05M-----
Non-Current Capital Leases------
Other Long-Term Liabilities------
Total Liabilities
3.03M1.37M1.18M1.24M-1.43M
Minority Interest------
Preferred Stock------
Common Stock Net50.77M46.7M47.76M47.66M47.54M46.87M
Capital Surplus4.27M3.99M3.96M3.79M3.73M3.69M
Retained Earnings-38.21M-35.8M-34.76M-32.9M-30.4M-28.57M
Treasury Stock------
Other Liabilities------
Shareholders Equity17.07M14.9M16.96M18.56M20.88M21.99M
Total Liabilities & Shareholders Equity20.1M16.27M18.15M19.8M21.87M23.43M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Looking at Acasti Pharma historical stock prices and the current Acasti Pharma stock price can tell you how the stock price has moved, whereas the Acasti Pharma PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: ACST total assets, which was at $20.1M for 2017 Q1 is a balance sheet item representing value of what Acasti Pharma owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Acasti Pharma's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for ACST stock stand at $3.03M.

Acasti Pharma Balance Sheet - Key Ratios

Current ratio
0
Debt to equity ratio
0
Asset turnover ratio
0
Receivables turnover
0